Recent advances in hereditary angioedema self-administration treatment: Summary of an international hereditary angioedema expert meeting

International Archives of Allergy and Immunology

Volumn 161, Issue SUPPL.1, 2013, Pages 26-27

  Craig, Timothy J ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR;

ANGIONEUROTIC EDEMA; CONFERENCE PAPER; FOLLOW UP; HEALTH CARE PERSONNEL; HOME CARE; HUMAN; MEDICAL LEAVE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ANGIOEDEMAS, HEREDITARY; COMPLEMENT C1 INACTIVATOR PROTEINS; HUMANS; SELF ADMINISTRATION;

EID: 84877952347     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000351241     Document Type: Conference Paper

References (4)

1. Cicardi M, Craig TJ, Martinez-Saguer I, Hébert J, Longhurst HJ: Review of recent guidelines and consensus statements on hereditary angioedema therapy with focus on self-administration. Int Arch Allergy Immunol 2013; 161(suppl 1):3-9.
2. Caballero T, Sala-Cunill A, Cancian M, Craig TJ, Neri S, Keith PK, Boccon-Gibod I, Bethune C, Bork K: Current status of implementation of self-administration training in various regions of Europe, Canada and the USA in the management of hereditary angioedema. Int Arch Allergy Immunol 2013; 161(suppl 1):10-16.
3. Symons C, Rossi O, Magerl M, Andritschke K: Practical approach to self-administration of intravenous C1-INH concentrate: a nursing perspective. Int Arch Allergy Immunol 2013; 161(suppl 1):17-20.
4. Boysen HB, Bouillet L, Aygören-Pürsün E: Challenges of C1-inhibitor concentrate selfadministration. Int Arch Allergy Immunol 2013; 161(suppl 1):21-25.